Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||- / 1||- / -|
Administered by: Other Purchased by: ??
Symptoms: Lymphadenopathy, SARS-CoV-2 test
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Medical History/Concurrent Conditions: Suspected COVID-19
Diagnostic Lab Data: Test Date: 20210326; Test Name: COVID-19 virus test; Test Result: Positive ; Test Date: 202106; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:not tested positive; Comments: since having the vaccine
CDC 'Split Type': GBPFIZER INC2021655437
Write-up: Swollen lymph nodes; This is a spontaneous report from a contactable consumer received from the regulatory authority (RA). The regulatory authority report number is GB-MHRA-WEBCOVID-202106040634485900-SEXV2, Safety Report Unique Identifier GB-MHRA-ADR 25417918. A 38-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 02Jun2021 (Lot number and expiry date were not reported) as single dose for COVID-19 immunisation. Medical history included suspected COVID-19 from 25Mar2021 to 04Apr2021. Patient is not enrolled in clinical trial. The patient''s concomitant medications were not reported. The patient experienced swollen lymph nodes (medically significant) on 04Jun2021 with outcome of not recovered. The patient had positive COVID-19 virus test on 26Mar2021. Patient has not tested positive for COVID-19 in Jun2021 since having the vaccine. No follow-up attempts are possible; information about the lot number cannot be obtained. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166